Literature DB >> 11747255

Effects of partial liquid ventilation with FC-77 on acute lung injury in newborn piglets.

Mei-Jy Jeng1, Yu Ru Kou, Ching-Chung Sheu, Betau Hwang.   

Abstract

Partial liquid ventilation (PLV) with various types of perfluorochemicals (PFC) has been shown to be beneficial in treating acute lung injury. FC-77 is a type of PFC with relatively high vapor pressure and evaporative losses during PLV. This study tested the hypothesis that using FC-77 for PLV with hourly replacement is effective in treating acute lung injury. Fifteen neonatal piglets were randomly and evenly divided into 3 study groups: 1) lavage-induced lung injury followed by conventional mechanical ventilation (Lavage-CMV); 2) lavage-induced lung injury followed by PLV using FC-77 with hourly replacement (11.2 +/- 1.5 mL/kg/hr) (Lavage-PLV); and 3) sham lavage injury followed by conventional mechanical ventilation (Control). Immediately after induction, repeated saline lavages induced acute lung injury characterized by decreases in dynamic lung compliance, arterial oxygen tension, and arterial pH, and increases in arterial CO(2) tension and oxygenation index, whereas the sham lavage procedure failed to do so. During the 3-hr period of CMV, these pulmonary and cardiovascular parameters remained stable in the Control group, but deteriorated in the Lavage-CMV group. In contrast, after acute lung injury, low lung compliance, abnormal gas exchange, acidosis, and inadequate oxygenation significantly improved in the Lavage-PLV group. Histological analysis of these 3 study groups revealed that the Lavage-CMV group had the highest lung injury score and the Control group had the lowest. These results suggest that, in comparison to CMV, PLV with FC-77 and hourly replacement of FC-77 promotes more favorable pulmonary mechanics, gas exchange, oxygenation, and lung histology in a piglet model of acute lung injury. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11747255     DOI: 10.1002/ppul.10021

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  5 in total

1.  Inhibition of inflammatory responses by FC-77, a perfluorochemical, in lipopolysaccharide-treated RAW 264.7 macrophages.

Authors:  Hung Chang; Fu-Chang Kuo; Yuan-Shu Lai; Tz-Chong Chou
Journal:  Intensive Care Med       Date:  2005-06-02       Impact factor: 17.440

2.  Effect of continuous hemofiltration on hemodynamics, lung inflammation and pulmonary edema in a canine model of acute lung injury.

Authors:  Xiao Su; Chunxue Bai; Qunying Hong; Duming Zhu; Lixian He; Jianping Wu; Feng Ding; Xiaohui Fang; Michael A Matthay
Journal:  Intensive Care Med       Date:  2003-10-14       Impact factor: 17.440

3.  Characterization of a reverse-phase perfluorocarbon emulsion for the pulmonary delivery of tobramycin.

Authors:  Ryan A Orizondo; Charlene Irvin Babcock; Mario L Fabiilli; Leonid Pavlovsky; J Brian Fowlkes; John G Younger; Keith E Cook
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2014-01-29       Impact factor: 2.849

4.  An Unsettled Promise: The Newborn Piglet Model of Neonatal Acute Respiratory Distress Syndrome (NARDS). Physiologic Data and Systematic Review.

Authors:  Dietmar Spengler; Nele Rintz; Martin F Krause
Journal:  Front Physiol       Date:  2019-10-30       Impact factor: 4.566

5.  M1 macrophage features in severe Plasmodium falciparum malaria patients with pulmonary oedema.

Authors:  Aekkarin Klinkhamhom; Supattra Glaharn; Charit Srisook; Sumate Ampawong; Srivicha Krudsood; Stephen A Ward; Parnpen Viriyavejakul
Journal:  Malar J       Date:  2020-05-15       Impact factor: 2.979

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.